As shown in the four studies presented below, the JETi™ System demonstrates positive clinical outcomes in a variety of thrombosis cases.
Pin, R. on behalf of the JETi Registry Investigators, Primary analysis of the novel JETi™ mechanical thrombectomy system for the treatment of arterial thrombosis. LINC, Leipzig, Germany 2024 May 28-31.
The JETi Registry (JETi Peripheral Thrombectomy Registry NCT04370691) is an all-comers, prospective, single-arm, multicenter, post-market study designed to collect real-world data on the JETi™ Hydrodynamic Thrombectomy System.
Razavi et al., JVIR. 2021.
Prospective study investigating single-session treatment of iliocaval and iliofemoral venous thrombosis while evaluating potential for treatment on an outpatient basis.
Khalsa et al., JVIR. 2020.
Retrospective review of 30 patients treated with JETi for acute lower extremity venous thrombosis.
Cournoyer-Rodrigue et al., JVIR. 2019.
Retrospective evaluation of 18 consecutive acute venous thrombosis patients at a new JETi user facility.
MAT-2202242 v2.0
You are about to enter an Abbott country- or region-specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions
Do you wish to continue and enter this website?
MAT-2305078 v1.0
